Prophylactic and therapeutic HPV immunization

被引：0
|
作者：
Mueller, M. [1 ]
Gissmann, L. [1 ]
机构：
[1] Deutsch Krebsforschungszentrum, Immunochem Abt, D-69120 Heidelberg, Germany
来源：
HAUTARZT | 2007年 / 58卷 / 06期
关键词：
papilloma virus; cervical carcinoma; prophylactic vaccine; therapeutic vaccine; HPV vaccine;
D O I：
10.1007/s00105-007-1346-5
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Papilloma viruses (PV) have been known to cause benign and malignant tumors in animals for more than 100 years. It took over 20 years to win general acceptance for their causative role in anogenital carcinomas in humans in particular in cervial carcinoma. Extensive research has led to the development of a prophylactic vaccine which is now commercially available. It remains to be investigated if HPV-specific therapeutic vaccines can be developed.
引用
收藏
页码：483 / +
页数：5
相关论文
共 50 条
  • [21] Genital HPV infection and prophylactic HPV vaccines
    Arvas, Macit
    Gezer, Altay
    Guralp, Onur
    TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS, 2008, 43 (01):
  • [22] Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization
    Kirnbauer, R
    Chandrachud, LM
    ONeil, BW
    Wagner, ER
    Grindlay, GJ
    Armstrong, A
    McGarvie, GM
    Schiller, JT
    Lowy, DR
    Campo, MS
    VIROLOGY, 1996, 219 (01) : 37 - 44
  • [23] IMMUNIZATION AND OTHER PROPHYLACTIC MEASURES
    ROODYN, L
    BRITISH MEDICAL JOURNAL, 1974, 4 (5945): : 648 - 650
  • [24] THE PRESENT STATUS OF PROPHYLACTIC IMMUNIZATION
    不详
    BRITISH MEDICAL JOURNAL, 1957, 2 (JUL27): : 212 - 213
  • [25] Development of prophylactic HPV vaccines
    Gissmann, Lutz
    Muller, Martin
    COLLEGIUM ANTROPOLOGICUM, 2007, 31 : 113 - 115
  • [26] Vasculitis following HPV immunization
    Gomes, Sonia Melo
    Glover, Mary
    Malone, Marion
    Brogan, Paul
    RHEUMATOLOGY, 2013, 52 (03) : 581 - 582
  • [27] Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial
    Karimi-Zarchi, Mojgan
    Allahqoli, Leila
    Nehmati, Ameneh
    Kashi, Abolfazl Mehdizadeh
    Taghipour-Zahir, Shokouh
    Alkatout, Ibrahim
    BMC PUBLIC HEALTH, 2020, 20 (01)
  • [28] Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial
    Mojgan Karimi-Zarchi
    Leila Allahqoli
    Ameneh Nehmati
    Abolfazl Mehdizadeh Kashi
    Shokouh Taghipour-Zahir
    Ibrahim Alkatout
    BMC Public Health, 20
  • [29] PROPHYLACTIC EFFECT OF IMMUNIZATION WITH ADENOVIRUS VACCINE
    ROSE, HM
    COOCH, JW
    KNOX, AW
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1957, 50 (06): : 946 - 947
  • [30] Potential effectiveness of prophylactic HPV immunization for men who have sex with men in the Netherlands: A multi-model approach
    Bogaards, Johannes A.
    Mooij, Sofie H.
    Xiridou, Maria
    van der Loeff, Maarten F. Schim
    PLOS MEDICINE, 2019, 16 (03)
12345